Skip to NavigationSkip to content

Pharmafile - Medical Communications News

With the retirement of Elias Zerhouni as Head of Global R&D, Sanofi had to find a suitable replacement and believes it has found the man in John...
With in-depth features on mobile health, clinical trials and Brexit, and the future of patient-reported outcomes, as well as interviews with Amicus...
It's the end of another week and there's really been one story that has dominated the headlines – Takeda’s potential takeover of Shire. It should...
Eli Lilly and Incyte are facing more complications in the US approval of their experimental rheumatoid arthritis (RA) drug baricitinib after the...
A research team in Basel have developed an exciting new skin implant which can serve as an early warning system for four of the most common cancers...
After the FDA advisory committee unanimously recommended GW Pharma’s Epidiolex for approval, the chances of it not receiving the nod are now slim to...
Allergan performed an odd about-turn after initially declaring its interest in pursuing a deal for Shire, before reneging on that statement only a...
BenevolentAI, a London based drug discovery biotech, has revealed that a $115 million financing round now sees the company valued beyond $2 billion.
Dr John Tsai has been welcomed to the fold as Novartis’ new Head of Global Development and Chief Medical Officer, stepping into the role vacated by...
The first stage of separation for the EMA from the UK came with the decision to relocate its headquarters to Amsterdam, and now the second stage has...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches